NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression

Abstract

Our results demonstrated that NEAT1 could sponge miR-23a-3p and functions via the expression of KLF3. This axis of NEAT1/miR-23a-5p/KLF3 could together regulate melanoma cancer proliferation. This might provide a new therapeutic strategy for melanoma skin cancer.<i>Trial registration</i> HBTCM38574839, registered 12 October 2012.